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Prostate cancer (PCa) is the second most common cancer in men, and the sixth leading cause of cancer death 
among men worldwide (1). Radical Prostatectomy (RP) is widely considered a gold standard treatment for 
clinically significant localized PCa in men considered eligible for radical treatment.  Radical prostatectomy can 
be offered as open, laparoscopic, or robot-assisted procedure depending on surgeon experience and 
institutional availability of equipment.  
 
Modern urological practice has seen the rise of robotic assisted surgeries, robotic assisted laparoscopic radical 
prostatectomy (RALP) being at the forefront. There has been a rapid increase in the number of American and 
European centers performing RALP over the last decade. The use of robotics in surgery in South Africa is in its 
relative infancy, with only six robot systems operating in the entire country at the time of writing this article.  
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The benefits of having available to the surgeon a comfortable seated position, magnified binocular 3D 
visualization and number of ergonomic, highly articulated and non-fatigable robotic arms within the tight 
confines of the boney pelvis seem obvious. Although this new approach appears to offer many benefits to 
patients, surgeons and institutions alike, some remain hesitant to adopt it for fear of a difficult learning curve 
that, while undertaken, may compromise functional and oncologic outcomes. As such there has been observed 
a growing interest over recent years in analyzing and understanding the learning process surrounding RALP. 
 
The general definition of a learning curve is the period during which a surgeon finds the procedure more 
technically challenging; takes longer to perform; a higher rate of complications is observed; and there is overall 
lower efficacy because of inexperience. With repetition one typically sees an improvement in these areas with 
obvious benefit to patients, surgeons, institutions and funders alike.  
The aim of the study is to demonstrate a progression in the learning curve of two South Africa based 
urologists, as each embarks on their first ever series of RALP cases between September 2014 to July 2019. 
Given there exists no widely accepted definition nor measure of a learning curve, as a surrogate, we seek to 
assess for improvements in key parameters as each surgeon gains experience with the procedure. An audit of 
these key parameters for each surgeon’s first uninterrupted series of RALP’s has been undertaken. We also 
compare our results to international series with a similar study design, to assess if local South African learning 
curves are similar to these. 
 
The chosen parameters have been selected to be in line with those already defined in already published 
international literature, allowing for better comparisons to be made (2–20). 
Pre-operative data collected will be required for risk stratification grouping of patients according to the 
D’Amico Risk group classification. The pre-operative data collected includes:  
[A] mean age at time of surgery,  
[B] PSA value at diagnosis, 
[C] clinical digital rectal findings, and  
[D] biopsy Gleason score (ISUP grading) 
 
Post-operative data included the following:  
[1] operating/console time, excluding setup/docking time (min), 
[2] estimated blood loss (ml), 
[3] need for intraoperative blood transfusion (yes/no),  
[4] conversion to open surgery (yes/no), 
[5] length of post-operative hospital stay (days),  
[6] number of patients with positive surgical margins (positive/negative),  
[7] percentage of patients in each cohort dry (i.e., not incontinent) at 2/3 and 6 months (%). 
Incontinence was a subjective questioning of the patient about being dry. 
[8] percentage of patients in each cohort potent (i.e., not suffering from erectile dysfunction) at 2/3 
and 6 months (%). Potency was assessed using the International Index of Erectile Function (IIEF-5) 
score. 
[9] histological (i.e., Gleason scope or ISUP grading), and  
[10] pathological (i.e. TNM staging) data.  
 
Although available literature reports on similar outcomes in international series, to our knowledge there have 
been no published analysis of South African data. We postulate that in a south African setting we would see 
similar improvements in key parameters and outcomes when compared to international cohorts. 
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ii) Literature review 
 
Pubmed and Google searches were done looking for learning curve of robotic assisted laparoscopic radical 
prostatectomy.  In total seventeen journal articles related to the learning curve of robotic assisted 
laparoscopic radical prostatectomy (RALP) were identified to be of help in preparing our research manuscript. 
Herewith a summary of the articles used and the impact it had in our study: 
 
1) Developing a Robotic Prostatectomy Service and a Robotic Fellowship 
Programme – Defining the Learning Curve 
Current Urology 2013; 7: 136–144 
Nikhil Vasdeva, Conrad Bishopa, Atoine Kass-Iliyya, Sami Hamid, Thomas A. McNicholas, Venkat 
Prasad, Gowrie Mohan-S, Timothy Lane, Gregory Boustead, and James M. Adshead. 
Department of Urology and Anaesthetics, Hertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, 
Stevenage, UK 
 
Researchers at a urology oncology centre in the UK retrospectively assessed the learning curve of the 3 
surgeons with regard to peri-operative outcomes and oncological results as they underwent their learning 
curve. This was conducted in an institution recognized by the Royal College of Surgeons of England/British 
Association of Urological Surgeons as the first robotic fellowship training programme in the UK. All 3 surgeons 
had extensive previous experience in laparoscopic, open and perineal radical prostatectomies. 
 
300 consecutive patients who underwent robotic radical prostatectomy (RRP) between Nov 2008 – Aug 2012 
were analysed. The total number of patients were broken down into three equal groups labelled: Group-1 [1–
100]; Group-2 [101–200]; and Group-3 [201–300].  Specific parameters and outcomes were compared across 
the 3 groups to assess the impact of the learning curve for the procedure.  
 
Assessed parameters and outcomes similar to our study pre-operative data collected included: age at time of 
surgery; PSA level; clinical digital rectal findings; pre-op biopsy Gleason score. Post-operative data included: 
operating time; estimated blood loss; need for intraoperative blood transfusion; need for conversion to open 
surgery; length of post-operative hospital stay (LOS); pathological data (i.e. histology and TNM stage); positive 
surgical margin (PSM) status; and continence and potency status post-op  
Assessed parameters and outcomes not included in our study were: ASA-score; pre-operative co-morbidities; 
previous abdominal surgery; duration of catheterization; and complications according to the Clavien-Dindo 
system. 
 
Age, ASA score, pre-operative co-morbidities and indications for laparoscopic radical prostatectomy were 
comparable for all three patient groups. 
 
The mean console time for the whole cohort was 224 minutes (range 95–522 min). The mean console time for 
Groups 1 to 3 was (217 ± 72.6min); (185 ± 51.7min); and (132 ± 38.7min) respectively (p < 0.001). 
 
The requirement for intra-operative blood transfusion was 2.3%. There were no conversions to open surgery 
reported in the cohort. 
 
The mean length of post-op hospital stay (LOS) for the entire cohort was 2.3 days (range 1–12 days). Patients 
in Group-3 (1.86 ± 1 days) had a significantly shorter stay than in Group-1 (2.58 ± 1.8) ( p = 0.001). The mean 
duration of catheterisation improved with each successive Group 1 to 3: (11.2 ± 2.8days); (9.1 ± 3.5days) and 
(7.9 ± 2.9days) respectively (p = 0.001).  
 
In the entire cohort of 300 patients the overall positive surgical margin (PSM) rate was 26.7%. The incidence 
sub pT2 tumours was 71.6%, for pT3 tumours 26.6% and for pT4 tumours 1.6% (although only 4 were pT4). 
PSM rates showed improvements among all three surgeons as they progressed through their series. The 
incidence of PSM in Groups 1 to 3 was: 22%, 32%, and 25% respectively (p= 0.02). Of importance is that there 
were greater numbers of pT3 tumours in Group-3 than in Groups-1 and Group-2. Higher rates of PSM’s were 
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experienced among stage pT3 and pT4 (p < 0.01), as well as and serum PSA levels > 10 mg/dl at diagnosis (p = 
0.044).  
 
The authors concluded that RRP is a safe procedure with low morbidity. As surgeons progress through the 
learning curve peri-operative parameters and oncological outcomes improve. With appropriate support, 
training and mentorship RRP can be taught to other surgeons and fellows in a structured mentored modular 
approach while continuing to improve outcomes for patients. Using a carefully structured mentored approach, 
RRP can be safely introduced as a new procedure without compromising patient outcomes. 
 
This study is applicable to ours in that it measures similar parameters and outcomes as there is a progression 
of the three surgeons through their learning curve. Of note is that most of the included outcomes are similar 
to our own and therefore provide a basis for comparison to our study. The outcomes assessed in this study 
that would have been beneficial in our own are: previous abdominal surgery; duration of catheterization; and 
complications according to the Clavien-Dindo system. The fact that the training of the three surgeons was 
done within a accredited robotic fellowship program would likely suggest that this studies results would 
provide a good benchmark with which to compare our own. 
 
2) Learning Curve of Robotic Radical Prostatectomy 
European Medical Journal Urology, Vol 3, Iss 3, Pp 50-55 (2015) 
Muhammed Ersagun Arslan,  Abdullah Erdem Canda, Ali Fuat Atmaca,  Mevlana Derya Balbay,  Ziya 
Akbulut, Serkan Altinova, and Ahmet Tunc Ozdemir. 
Department of Urology, Ankara Ataturk Training and Research Hospital, Ankara, Turkey 
 
Researchers at an academic hospital in Turkey retrospectively assessed a total of 391 patients who underwent 
a robotic-assisted laparoscopic radical prostatectomy (RARP) in their institution between Feb 2009 - April 2013 
among 6 surgeons. The patients were divided into six groups according to the surgeon: group-1 (n=72), Group-
2 ( n=110), group-3 (n=103), group-4 (n=38), group-5 (n=36), group-6 (n=32). Surgeons 1, 2, and 3 performed 
the highest volume of procedures and their cases were also examined as three consecutive series in order to 
evaluate improvement over time 
 
Assessed parameters and outcomes similar to our study pre-operative data collected included: age at time of 
surgery; PSA level; clinical digital rectal findings; pre-op biopsy Gleason score. Post-operative data included: 
operating time; estimated blood loss; need for intraoperative blood transfusion; need for conversion to open 
surgery; length of post-operative hospital stay; pathological data (i.e. histology and TNM stage); positive 
surgical margin status; biochemical recurrence status; and continence and potency status post-op.  
Assessed parameters and outcomes not included in our study were: BMI; ASA score; IPSS score; anastomosis 
time; and complications. 
 
The three consecutive series of the surgeons with the highest volume of cases (Surgeon-1, -2, and -3) were 
analysed with regard to operating time (OT), estimated blood loss (EBL), requirement for intra-op blood 
transfusion, and positive surgical margin (PSM) rate.  
 
In the three series of Surgeon-1, OT was shown to decrease significantly between each consecutive series 
(p<0.001). For Surgeon-2, OT was revealed to decreased significantly between the first and second series, 
although not between the second and third series (p<0.001). For Surgeon-3, OT decreased significantly 
between the second and third series.  
 
EBL decreased significantly in each consecutive series of Surgeon-3 (p<0.001), whereas EBL in the consecutive 
series of Surgeons-1 and -2 showed a trend towards decreasing in the second and third series when compared 
with the first series, although this failed to reach statistical significance (p>0.05). The blood transfusion rate 
was significantly higher in Surgeons-1’s first series compared with his second and third series (p=0.015).  
 
Overall, PSM rates did not change significantly in any of the three surgeons’ series, although the rate in 
Surgeon 2’s third series was significantly higher than in the second series with regard to pT3 stage tumours 
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The median International Index of Erectile Function (IIEF) scores of Surgeon-1’s group at 12 months were 13 
(range: 6-26) for the first series, 6 (range: 6-24) for the second series, and 21 (range: 6-25) for the third series, 
which showed a significant improvement in the third series (p<0.001). The median IIEF scores of Surgeon-2’s 
group at 12 months were 6 (range: 6-26) for the first series, 18 (range: 6-26) for the second series, and 18 
(range: 6-28) for the third series, which showed a significant improvement in both the second and third series 
(p=0.01). The median IIEF scores of Surgeon 3’s group at 12 months were 19 (range: 6-26) for the first series, 
16 (range: 6-25) for the second series, and 20 (range: 6-28) for the third series, which showed no statistically 
significant difference between series (p>0.05).  
 
The continence rates for Surgeon-1’s group at 12 months were 95.8%, 83.3%, and 100% for the first, second, 
and third series, respectively. The continence rates for Surgeon-2’s group at 12 months were 100%, 97.3%, and 
100% for the first, second, and third series, respectively. The continence rates of Surgeon-3’s group at 12 
months were 91.4%, 100%, and 97% for the first, second, and third series, respectively. The 12-month 
continence rate of Surgeon-1’s group was significantly lower in the second series than in the first and third 
series (p=0.017), but there was no significant difference in the series of Surgeon-1 and Surgeon - (p>0.05). 
 
The overall complication rate was 11.7% and 34% of these complications were major ones. The overall blood 
transfusion rate was 2%. The overall PSM rate was 20.4% (9.3% for pT2 tumours and 44% for pT3 tumours). 
The overall rate of BCR was 9.4%. 
 
In summary, when assessing the 3 consecutive series of the three highest-volume surgeons they found that, 
over time, for Surgeon-1: operation time (OT) decreased significantly (p<0.001), blood transfusion rate 
decreased significantly (p=0.015), estimated blood loss (EBL) decreased (p>0.05), and median IIEF score at 12 
months improved significantly (p<0.001). For Surgeon-2; OT decreased significantly (p<0.001), EBL decreased 
(p>0.05), and median IIEF score at 12 months improved significantly (p=0.01). For Surgeon-3: OT decreased 
significantly (p<0.001), EBL decreased significantly (p<0.001), and PSM rate decreased and median IIEF scores 
at 12 months improved (p>0.05 for both). 
 
The authors concluded that there were significant improvements in OT, EBL, and blood transfusion rates with 
increasing surgeon experience. There was not a significant change in PSM rates. The OT, EBL, blood transfusion 
rates, overall complication rates, PSM rates, BCR rates, continence, and potency rates were all similar to 
previously published studies of RARP. Therefore, RARP can be performed relatively safely even in the learning 
curve period and the outcomes improve with experience 
 
This study is applicable to ours in that it measures similar outcomes as there is a progression of the three 
surgeons through their learning curve. Of note is that most of the included outcomes are similar to our own 
and therefore provide a basis for comparison to our study. Outcomes assessed in this study that would have 
benefitted our own include BMI and Anastomosis time, as these may provide some insight into how 
challenging the surgery may be and increasing competence of the surgeon respectively. Complications seem a 
common theme among these studies that was not fully assessed in our patient cohorts and would likely have 
been very useful and an outcome to assess progression during the learning curve.  
 
3) Robotic Radical Prostatectomy in the Community Setting - The Learning 
Curve and Beyond: Initial 200 Cases. 
Journal of Urology, Vol. 174, 269–272, July 2005 
Patel VR, Tully AS, Holmes R, and Lindsay J. 
From the Urology Centres of Alabama, Birmingham, Alabama 
 
Researchers in the USA looked at 200 patients who underwent RALP during a 18month period. This article 
refers to Dr VR. Patel’s first ever analysis of single surgeon and singe centre experience. The 200 patients in the 
cohort were conveniently divided and then analysed in consecutive groups of 50 cases.  Patients were 
followed up for a mean of 9.7 months.  
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
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hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: drop in patient haematocrit; catheter 
time; and complications. 
 
The operative time (OT) was defined as the time taken from skin incision to fascial closure (the time that 
the surgeon was present). The mean overall OT was reported in this study to be 141min, while the mean 
operative time for the consecutive four groups of 50 cases was reported as: 202min, 153.1min, 112.9min; and 
106.4min respectively. The mean overall EBL was reported as 75.1ml, while the mean EBL for the consecutive 
four groups of 50 cases was reported as: 151.2ml, 64.4ml, 34.1ml; and 48.3ml respectively. The mean 
difference in pre-operative vs post-operative hematocrit was reported as 3 points (range -2 to 15)There were 
no transfusions during this series of RALP’s 
 
The mean duration of post-operative catheterization was 7.9days (range 5-21days). The discharge rate on day 
one post-surgery was given as 95%.  
 
The PSM rate (presence of cancer cells at the inked margin) was 10.5% for the whole series while among T2, T3 
and T4a tumours the PSM rate was reported as 5.7%, 26.2% and 33% respectively. When pts were looked at as 
the first 100 cases vs the second 100 cases the PSM rate was 13% vs 8%. 
 
Continence at 1-, 3-, 6-, 9- and 12-months was reported in the study as: 47%, 78%, 89%, 92% and 98%, 
respectively.  
 
The authors concluded that in their initial experience of 200 RALP’s, the learning curve was approximately 20- 
25 cases and that their feeling was that RALP could be safely and effectively into integrated into the 
management of localized prostate cancer with minimal patient morbidity, and good oncological and functional 
outcomes. 
 
This study is applicable to ours in that Dr Patel would later in his career go on to become one of the eminent 
robotic surgeons in modern times, and he has become known for his good oncological and functional 
outcomes with regards to RALP. As his cohort was broken down into consecutive groups of 50 for his first ever 
series of 200 cases, this study can provide a valuable benchmark with which to compare our study. It is also 
the study where Dr Patel is famously quoted as saying that the initial learning curve is 20-25cases.   
 
4) Robotic radical prostatectomy: outcomes of 500 cases 
British Journal of Urology International. 2007 May; 99(5):1109-12. 
Vipul R. Patel, Rahul Thaly and Ketul Shah. 
Centre for Robotic and Computer Assisted Surgery, Division of Urology, Ohio State University, Columbus, OH, USA 
 
Researchers at a centre of excellence report on the outcomes of 500 who underwent RALP over a 30-month 
period. This article refers to Dr VR. Patel’s single surgeon and singe centre experience. 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: quality-of-life questionnaires; BMI; 
catheter time; and complications. 
 
The operative time (OT) was defined as the time taken from skin incision to fascial closure (the time that 
the surgeon was present). The mean OT was reported in this study to be 130min (range 51–330 min), while the 
mean operative time for the 50 cases was 202 min, and the mean operative time for patients 400-500 was 
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<100 min. The mean EBL was reported as 50ml (range 10–300ml) and was noted to decrease as the surgeon 
gained experience. There were no transfusions during RALP, and the rate post-surgery was 0.4%.  
 
The mean duration of post-operative catheterization was 6.9days (range 5-21days). The discharge rate on day 
one post-surgery was given as 97%.  
 
The PSM rate was 9.4% for the whole series while among T2, T3a, pT3b and T4 tumours the PSM rate was 
reported as 2.5%, 23%, 46%, and 53% respectively. The PSM rate for patients 1–100 was 13%; patients 101–
200 was 8%; patients 201–300 was 13%; patients 301–400 was 5%; and patients 401–500 was 8%. At a mean 
follow-up of 9.7 months, the overall biochemical recurrence free survival was 95%, using a cut off PSA level of 
< 0.1 ng/ml. 
 
27% of patients were reported as immediately continent (no significant leak after catheter removal), and the 
completely continent rate at 3 and 6 months follow up was reported as 89% and 95% respectively. At 1 year 
follow up 78% of patients were reported as being potent (+/- requirement of oral medications), while 15% 
were unable sustain erections capable of penetration, and 7% were using inter-cavernosal injection therapy to 
achieve a satisfactory erections.  
 
The authors concluded that their initial experience with the procedure showed promising short-term 
outcomes and that RALP was both safe and feasible to introduce into the management of localized prostate 
cancer. They also stated that while the initial learning curve was short, additional training was needed when 
level of complexity of the cases increased. Patients with a greater BMI (>35); a history of previous TURP, and 
prostates weighing >100 g provided for challenging cases. 
 
This study is applicable to ours in that Dr Patel and his centre of excellence is regarded very highly in terms of 
functional and oncological outcomes for patients undergoing RALP for adenocarcinoma of the prostate. As his 
cohort was broken down into consecutive groups of 100 for the PSM rate and to some extent the operating 
time, the results provides insight into Dr Patel’s first ever series of RALP patients and provides a valuable 
benchmark with which to compare our study.   
 
5) Robot-Assisted Laparoscopic Radical Prostatectomy: Perioperative 
Outcomes of 1500 Cases 
JOURNAL OF ENDOUROLOGY, Volume 22, Number 10, October 2008 
Vipul R. Patel, Kenneth J. Palmer, Geoff Coughlin, and Srinivas Samavedi. 
Centre for Robotic and Computer Assisted Surgery, Division of Urology, Ohio State University, Columbus, OH, USA 
 
Again, researchers at this centre of excellence report on the outcomes of now 1500 consecutive patients who 
underwent RALP for adenocarcinoma of the prostate in their institution. Again, this article refers to Dr VR. 
Patel’s single surgeon and singe centre experience. 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: BMI; catheter time; prostate size; and 
complications. 
 
Mean operative time (OT) was 105min (range 55–300min). Mean estimated blood loss (EBL) was reported as 
111ml (range 50–500ml) and there was no requirement for intraoperative transfusion. No patients required 
conversion to open surgery, although they report one patient requiring conversion to standard laparoscopy 
after malfunction of the da Vinci system. Two figures (Fig.2 and Fig.3) are included in the article that show a 
downward trend in both OT’s in consecutive groupings of 300 patients. The author notes that OT’s and EBL 
tend to decrease with increasing experience of both the surgeon his team 
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97% of patients were discharged home on day one post-operation. The mean duration of catheterization was 
6.3days (range 4–28days). 
 
The overall PSM rate was reported as 9.3% for the whole series of 1500 patients. The PSM rate for pT2, pT3 
and pT4 disease was 4%, 33% and 40% respectively. Of note is that this is that there appears to be some 
improvement in the PSM rates compared to his first series of 500pts [3] where the rates for pT2, pT3 and pT4 
disease was 2.5%, 23%, and 53% respectively. Included in this article were lengthy discussion regarding the 
decreased complication rates with increased surgical experience, although  
 
The authors stated that the subjective initial learning curve to develop basic competence with the robotic 
system was 25 cases. Basic competence was defined as the point at which the surgeon felt comfortable with 
technology, procedure and OT times were <4hrs. There are a number of comparisons made to other 
contemporary RALP series to which Dr Patel’s series is compared. These comparisons were deemed favourable 
by the author.  
 
This study is applicable to ours in that a comparison can be made to his initial series of 500 patients 
(mentioned above) to be able to demonstrate that variables such as OT’s, EBL and PSM rate all improve further 
with increasing experience.  
 
6) Early Complication Rates in a Single-Surgeon Series of 2500 Robotic-
Assisted Radical Prostatectomies: Report Applying a Standardized 
Grading System 
European Urology. 2010 Jun;57(6):945-52.  
Coelho RF, Palmer KJ, Rocco B, Moniz RR, Chauhan S, Orvieto MA, Coughlin G, Patel VR. 
Global Robotics Institute, Florida Hospital Celebration Health, Celebration, Florida 34747, USA. 
 
Researchers in the US retrospectively assess the learning curve and peri-operative outcomes of 2500 
consecutive robot-assisted laparoscopic radical prostatectomy (RALP) performed by a single surgeon in their 
centre between August 2003 and February 2009. OF note this single surgeon was once again Dr VP Patel. The 
cases were divided into groups of 300 to make eight groups in total. The mean values of the 
parameters/outcomes in each group were then assessed. A median follow-up time of 25 months was reported 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: BMI; ASA-score; catheter time; and 
complications. 
 
For the entire cohort of 2500 cases, the median operative time (OT) was 90 min (rage: 75–100 min); the 
median estimated blood loss (EBL) was 100 ml (rage: 100–150 ml); median catheterization time was 5days 
(range: 4–6 days); conversion to open surgery was reported in 0.08% of cases; median length of hospital stay 
was 1 day; and 95% of patients were discharged after one day.  
 
The overall positive surgical margin (PSM) rate was reported in this study at 10.6% while for pT2 and pT3 
disease it was reported as 5% and 27.5% respectively. 
 
140 complications were observed in 127 patients in the whole series and the trend was reduced complications 
with increased surgeon experience. The authors also point out a lack of consistency in reporting complications 
among the published literature of the time. The Clavien-Dindo Classification was used in this study to report 
the complications.  
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The authors conclude that complication rates, along with the other parameters reported, were shown to 
decrease with increase surgeon experience. They recommended that a standardized classification system to 
analyse surgical complications would be needed in future studies so as to compare complication rates. 
 
This study is applicable to ours in that that it provides an update to Dr Patel’s series to now include 2500 
cases. The study also reflects on how complications can also decrease substantially with increase operator 
experience.  
 
7) Critical review of ‘pentafecta’ outcomes after robot-assisted 
laparoscopic prostatectomy in high-volume centres 
British Journal of Urology International, Volume 108, Issue 6, Sept 2011  
Patel VR, Abdul-Muhsin HM, Schatloff O, Coelho RF, Valero R, Ko YH, Sivaraman A, Palmer 
KJ, Chauhan S. 
Global Robotics Institute, Florida Hospital Celebration Health and Department of Urology, University of Central Florida College 
of Medicine, Celebration, FL, USA,   
Albert Einstein Jewish Hospital, Sao Paulo, Brazil,  
Department of Urology, University of Caracas, Venezuela , and  
Department of Urology, Korea University, South Korea 
 
Researchers in the USA did a review of the literature after performing a Medline search for articles related to 
the peri-operative outcomes related to robot-assisted laparoscopic prostatectomy (RALP) in high-volume 
centres. A large number of articles (>20) were individually assessed, and their data reported. Of interest to us 
is an updated report from Dr VP. Patel’s series that now includes 4000 patients performed by a single surgeon 
and in a centre of excellence.  Also of interest is that the weighted means of reported outcomes of 17-19 
studies were reported which allows for an overall picture of reported results. Both these have been reported 
in our study. The pe 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: biochemical recurrence rate and 
complications. 
 
Although this review looks at multiple studies, we have chosen to focus on Dr Patel’s series of 4000 cases as 
well as the weighted means of the 17-19 studies looked at. 
 
For Dr Patel’s series (PS) we see that after 4000 cases the OT we see the following mean values: 
Operative time (OT): 75min 
Estimated blood loss: 100ml 
Length of hospital stay (LOS): 1 day 
Overall positive surgical margin (PSM) rate: 10.8% 
pT2 and pT3 PSM rates: 5.8% and 26.1%  
 
For weighted means of the 17-19 studies: 
Operative time (OT): 174min 
Estimated blood loss: 185.8ml 
Length of hospital stay (LOS): 1.58 days 
Overall positive surgical margin (PSM) rate: 16.2% 
pT2 and pT3 PSM rates: 7.7% and 29%  
 
The authors concluded that RALP is a safe and effective procedure for localized prostate cancer. 
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This study is applicable to ours in that that it provides an update to Dr Patel’s series to now include 4000 
cases. We see that, besides the operative time decreasing substantially, the other parameters do not show 
such a dramatic decrease. Additionally, the summary of outcomes, including the weighted means of all the 
studies evaluated, are a useful comparison to our own outcomes.  
 
8) The first 1000 cases of laparoscopic radical prostatectomy in the UK: 
evidence of multiple ‘learning curves’ 
British Journal of Urology International, Volume 103, Issue 9, May 2009 
Christopher G. Eden, Mischel G. Neill and Mark W. Louie-Johnsun. 
Department of Urology, The Royal Surry County Hospital, Guildford, UK 
 
Researchers at in the UK report the initial experience of one surgeon’s first ever series of 1000 patients between March 
2000 and December 2007. Of note is that the surgeon involved had contemporary experience of >1000 patients in both 
open radical prostatectomy (ORP) and laparoscopic radical prostatectomy (LRP). 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: use of nerve sparing surgery; operating 
time; estimated blood loss; need for intraoperative blood transfusion; need for conversion to open surgery; 
length of post-operative hospital stay; pathological data (i.e. histology and TNM stage); positive surgical 
margin status; and continence and potency status post-op.  
Assessed parameters and outcomes not included in our study were: BMI; previous abdominal surgery; 
catheter time; and complications. 
 
The median operative time (OT) was 177min (range 78–600min). There was only one conversion to open 
surgery in the entire series. The median estimated blood loss (EBL) was 200ml (range 10–1300ml) and 4 (0.4%) 
patients requires intra-operative blood transfusion. Both of these parameters were assessed in consecutive 
groups of 50 patients with clear downward sloping of the trendline despite a number of peaks and troughs 
similar to our cohorts.  
 
The median length of post-operative hospital stay (LOS) was 3 days (range 3–28 days). The median 
catheterization time was 10 days (range 0.8–120 days). Again, both parameters were assessed in consecutive 
groups of 50 patients with clear downward sloping of the trendline despite wide variations in the reported 
medians.  
 
The positive surgical margin (PSM) rate overall was 13.3%, while the PSM rate for pT1, pT2 and pT3 disease 
was 5.2%, 18.5% and 56.3% respectively. When the PSM rate was assessed according to D’Amico risk groups 
the study reported rates of 9.1%, 20.3%, and 36.8% for low, intermediate and high risk respectively. At a mean 
follow-up of 27.7months the biochemical recurrence free survival was reported as 96.1%.  
 
Completely continent (i.e. no pads used) rates increased from 10% immediately after post-op catheter removal 
to 94.9% at a mean follow-up of 27.7months. A similar trend was seen when potency rate was assessed at 9% 
immediately post op, to 65.6% at a mean follow up of 27.7 months. Potency was reported being much higher 
in those patients < 65years of age when compared to older men in the series. 
 
The authors concluded that the learning curve for both OT and EBL plateaued within the first 100-150 cases, 
while that for both complication and continence rates took longer at 150-200 cases to reach a plateau. The 
parameter that took the longest to plateau was potency at 700 cases. The authors suggest that structured 
training programs and a high volume of cases would likely reveal better outcomes. Even then, a large RALP 
throughput will likely to be required in order to maintain competency so that clinical outcomes remain at the 
highest level. 
 
This study is applicable to ours in that the single surgeon’s whole series is broken into consecutive groups of 
50 cases so as to demonstrate the learning curve as it pertains to many of the outcomes we measured in our 
own study. The author also introduces the concept of an outcome reaching a plateau to suggest that a learning 
curve has been overcome. It is also the first study we came across that looks at PSM rates as they pertain to 
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the D’amico risk groups and thus provides a comparison for our own results, albeit with a much higher case 
volume.  
 
9) First 500 cases of robotic-assisted laparoscopic radical prostatectomy 
from a single UK centre: learning curves of two surgeons 
British Journal of Urology International, 108(5):739-47, December 2010 
Naomi Laura Sharma, Alexandros Papadopoulos, Dominic Lee, John McLoughlin, Sarah L. Vowler, 
Herve Baumert, Anne Y. Warren, Vishal Patil, Nimish Shah, and David E. Neal. 
Addenbrooke’s Hospital – Urology, Pathology and Anaesthetics; University of Cambridge – Oncology, Cambridge, UK, Cambridge 
Research Institute – Bioinformatics and Statistics, Cambridge, UK; and Paris Saint Joseph Hospital Trust – Urology, Paris, France 
 
Researchers at in the UK report the initial experience of two surgeon’s first ever series of 500 patients 
between 2005 and 2009. The learning curves of the two surgeons were assessed as it pertains to the outcomes 
listed below. Additionally, the outcomes of the first 100 and last 100 patients were compared to determine the 
effect of surgeon experience. Of note is that Surgeon-1 had mostly extensive experience in open 
prostatectomy, while Surgeon-2 had extensive laparoscopic experience; previous cadaveric laparoscopic 
prostatectomy training; and wet laboratory training with the robot. For both surgeons a structured mentoring 
programme was used for the implementation of robotic assisted laparoscopic radical prostatectomy (RALP) in 
their institution.  
 
Assessed parameters and outcomes similar to our study included pre-operative data such as: age at time of 
surgery; PSA level; clinical digital rectal findings; pre-op biopsy Gleason score; and D’amico risk groups. Post-
operative data included: use of nerve sparing surgery; operating time; estimated blood loss; need for 
intraoperative blood transfusion; need for conversion to open surgery; pathological data (i.e. histology and 
TNM stage); positive surgical margin status; and continence and potency status post-op.  
Assessed parameters and outcomes not included in our study were: prostate volume and weight and 
complications. 
 
Surgeon-1’s series included 330 cases while Surgeon-2’s series included 170 cases. Each surgeon had their 
cohort divided into consecutive groups of 50 patients to be able to assess the impact on the above parameters 
as each surgeon gained experience in RALP. For Surgeon-1 there were seven consecutive groups labelled: [1-
50]; [51-100]; [101-150]; [151-200]; [201-250]; [251-300]; and [301-330]. For Surgeon-2 there were four 
consecutive groups labelled: [1-50]; [51-100]; [101-150]; and [151-170]. It was noted in a breakdown of case 
complexity that there was a trend of cases to increase in risk for both surgeons, with more high-risk cases 
undergoing surgery from approximately case number 75 onward for each surgeon. This trend was also seen in 
our series. 
 
Median overall operating time (OT), excluding robotic setup time, was 170min (range 63–420min) for both 
surgeons combined (n = 500). For Surgeon -1’s consecutive seven groups the median OT’s were reported as: 
185min; 180min; 149min; 150min; 163min; 135min; and 131min respectively. For Surgeon-2’s consecutive 
four groups the median OT’s were reported as: 237min; 201min; 180min; and 177min respectively. The 
general trend for both surgeons was towards significantly shorter operating times with increasing experience 
(P<0.001). See FIG 2. in article for a graphic representation of median OT’s.  
 
Median overall estimated blood loss (EBL) was 200ml (range 20-3000ml) for both surgeons combined (n = 
500). For Surgeon -1’s consecutive seven groups the median OT’s were reported as:288ml; 225ml; 150ml; 
100ml; 250ml; 150ml; and 100ml respectively. For Surgeon-2’s consecutive four groups the median OT’s were 
reported as: 250ml; 250ml; 200ml; and 225ml respectively. Again, the general trend for both surgeons was 
towards significantly lower EBL with increasing experience (P = 0.029). See FIG 3. in article for a graphic 
representation of median EBL’s. 
 
The overall positive surgical margin (PSM) rate was 24% (for both surgeons combined (n = 500) while the PSM 
rate was 16.1% for pT2 disease and 85.4% for pT3 disease. For Surgeon-1’s consecutive seven groups the SPM 
rates were reported as:12%; 32%; 26%; 36%; 14%; 20%; and 20% respectively. For Surgeon-2’s consecutive 
four groups the median OT’s were reported as: 20%; 36%; 22%; and 25% respectively.  
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With one-year follow-up completely continent rate (i.e. no pads used), was 91.3% for the entire series. For the 
last 100 patients in the entire series the complexly continent rate was 83%, which was significantly better than 
reported 59% for the first 100 patients (P=0.007). At 48 months of follow-up, 75% of men who were potent 
prior to surgery and who underwent bilateral nerve sparing RALP continued to be potent (defined as an IIEF-5 
score> 16). In the total series (n=500) 69.2% of men had bilateral nerve-sparing surgery, while 19% and 11.8% 
had unilateral or no nerve-sparing surgery respectively.  
 
The authors conclude that with regards to the continued improvement in both OT’s and EBL by the end of each 
surgeon’s series, it is was possible to define a particular case number at which the learning curve has 
plateaued. They go on to suggest that with bigger case numbers we would likely see this plateau and thus be 
able to define a number. They point out that in a large multicentre retrospective study of almost 5000 patients 
who underwent laparoscopic radical prostatectomy there was a lower risk of recurrence with increasing 
surgeon experience, and this continued up to 750 cases [1]. This study highlights the importance of 
interpreting short-term learning curves with caution. 
 
This study is applicable to ours in that is the article that is most similar to our own in terms of two surgeons 
being analysed for their learning curves, and both their series being broken down into consecutive groups of 
50 patients.  With a similar study design we can more directly compare out local data to an international 
series. The trends displayed in the observed outcomes are strikingly similar to our own. Interestingly they also 
observed that not all outcomes improved with each sequential series as each surgeon gained experience. The 
increasing complexity of the cases as each surgeon progressed was offered as a potential explanation for this.  
 
10) Learning Curves for Robotic Surgery: a Review of the Recent Literature 
Current Urology Reports (2017) 18:89 
G. Mazzon, A. Sridhar, G. Busuttil, J. Thompson, S. Nathan, T. Briggs, J. Kelly, and G. Shaw. 
Institute of Urology, University College Hospital, London, UK 
 
A recent review of relevant literature regarding urological learning curves as it related to robotic assisted 
surgeries.  Learning curves (LC) for four different groups were looked at: Robotic Assisted Laparoscopic Radical 
Prostatectomies (RALP), virtual reality robotic simulator (VRS), robot-assisted radical cystectomy (RARC), and 
robot-assisted partial nephrectomy (RAPN). Our attention is focused solely on the section of the article that 
deals with RALP. 
 
The authors state that the current data available is extremely heterogeneous with little consistency in terms of 
a definition for learning curve, nor the parameters used as a surrogate to measure. Wheter previous 
experience in open radical prostatectomy (ORP) has an effect on RALP remains unclear. Herrel and Smith [2] 
showed that the LC for a surgeon who had performed over 2500 ORP plateaued at 250 procedures. Gumus et 
al. [3] was able to demonstrate a more rapid plateau in laparoscopically naïve surgeons between 50 and 120 
cases. 
 
It would appear that in high-volume centres, surgeons with considerable experience in ORP, who are now 
learning RALP for the first time, seem to have better oncological and functional outcomes [4, 5]. On the other 
hand, more recently, the urology trainees are exposed to robotic surgery directly without obtaining any 
substantial open surgery experience.  
 
Mean OT seems to reach a plateau after 50-200 robotic cases, while positive surgical margin (PSM) rate 
plateaus somewhere between 50-1600 cases, depending on the author’s definition of acceptable PSM rate [6-
8]. The plateau for length of stay (mean 1.13 days), pad-free continence, and potency took longer to reach at 
200 cases each.  
 
LC for laparoscopic prostatectomy (LRP) is well described by Vickers et al. [1]. The authors retrospectively 
collected results from 4702 laparoscopic radical prostatectomies (LRP) performed by 29 different surgeons. 
The 5-year risk of recurrence was 17% (10 cases) to 16% (250 cases) to 9% (750 cases). The risk reduction 
between 10 and 750 cases was reported as 8.0% (95% CI 4.4–12.0). LRP remains technically demanding and 
ergonomically more challenging than RALP.  
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As a consequence, RALP has been reported to have a shorter learning curve [9, 10]; however, these early 
reports did not have sufficient numbers to identify the plateau of the LC. Good et al. [11], in a study involving 
1370 patients, compared results of two different surgeons who were considered to have reached their LC 
plateau for both LRP and RALP. The surgeon-1 performed 289 LRPs and 531 RALPs, whereas surgeon-2 
performed 289 LRPs and 550 RALPs. Both groups had similar proportions of pT2/pT3 cases and similar 
proportions of nerve-sparing cases. LC duration was found to be essentially the same for operating time (OT), 
estimated blood loss (EBL), and complication rates (250 cases) whereas the plateau for the PSM rate was 
reached only later in RALP group (300 vs 250 cases for pT2 disease, p = 0.001 and 250 vs 200 cases for pT3 
disease, p=0.003). A sub-group analysis of the LC for apical PSM rate, however, showed a different picture 
since LC for RALP was 50 cases vs 200 cases for LRP (p<0.001). LC for early continence (EC) was significantly 
shorter for RALP: 350 cases (LRP group) vs 100 cases (RALP group) (p<0.001). This study demonstrates that 
RALP has a similar LC to LRP, and it cannot be considered as a procedure who’s skill set is easy to acquire. 
 
Furthermore, a recent multicentre study of PSM rates by Sooriakumaran and colleagues [8] demonstrated that 
a case load of >1000 cases was required before the PSM rate for pT3 disease plateaued. Continued 
improvement, despite extensive case load in the pT3 PSM, is a very interesting finding since pT3 prostate 
cancer is known to have a higher risk of biochemical recurrence (BCR) than pT2 disease.  The authors note that 
the resultant superior outcomes in this regard may well translate in a lower rate of BCR in RARP than LRP.  
 
An interesting consideration is whether or not RALP outcomes are adversely when a new surgeon, still early in 
their LC, is integrated into a high-volume robotic centre. Wang et al. [12] retrospectively analysed the 
outcomes of 3064 RALP’s performed between 2007-2012 in their centre. 2846 RALP’s were performed by 
three experienced robotic surgeons and 218 of these cases by a new surgeon added to the team. The new 
surgeons, under supervision for 12 months, performed 17-52 cases per year. Outcomes assessed included OT, 
EBL, PSM rate, biochemical recurrence and complications. Results showed that the only significant predictor of 
a decrease in probability of major complications was case number (Clavien-Dindo ≥ 3, p=0.025). Case number 
was a predictor of BCR (p=0.021), with 10.5% risk of BCR at year 1 and 6.6% after 6 years at commencement 
(p=0.009). Furthermore, case number influenced the OT (p = 0.004) but it did not influence PSM (p =0.816). 
Overall, the authors conclude that the new surgeon could be integrated into an existing robotic team without 
compromising the outcomes of the unit. 
 
The LC as it related to an extended pelvic lymphadenectomy (ePLND) at the time of RALP has also been looked 
at by Di Pierro and colleagues [13]. They prospectively collected data from an experienced single surgeon who 
performed 233 consecutive RALP plus ePLND cases. The total number of cases was divided chronologically into 
four quarters labelled groups-1 to -4. Although mean OT did not decrease significantly with experience, there 
was a significant higher number of resected lymph nodes in the specimens after 60 cases: group-1(13 nodes), 
group-2(15 nodes), group-3 (17nodes), and group-4 (16 nodes) (p=0.001). After 175 cases the there was a 
significant decrease in minor (Clavien-Dindo <3) complications observed. Minor complication rates were: 
group-1(34%), group-2(40%), group-3 (41%), and group-4 (17%) with no change seen in major complications ( 
=0.028). 
 
The authors of this literature review state that their review should inform both trainers and trainees on what 
outcomes they can expect with increasing experience in RALP. This will facilitate a safer and more efficient 
training programs for those starting out in RALP. 
 
11) A Critical Analysis of the Learning Curve and Post-learning Curve 
Outcomes of Two Experience and Volume-Matched Surgeons for 
Laparoscopic and Robot-Assisted Radical Prostatectomy 
Journal of Endourology. 2015 Aug;29(8):939-47 
Daniel W. Good, Grant D. Stewart, Alexander Laird, Jens-Uwe Stolzenburg, Declan Cahill, and S. Alan 
McNeill. 
Department of Urology, Western General Hospital, NHS Lothian, Edinburgh, United Kingdom 
Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, United Kingdom  
Department of Urology, University of Leipzig, Leipzig, Germany. 
Department of Urology, Guy's and St. Thomas' NHS Trust, London, United Kingdom. 
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Researchers in the UK and Scotland report on the peri-operative outcomes of two experience- and volume-
matched laparoscopic and robotic surgeons who have completed the learning curve with respect to 
laparoscopic radical prostatectomy (LRP) and robotic sssisted laparoscopic radical prostatectomies (RALP). 
Given RALP has been reported to have a faster learning curve compared to LRP, the authors of this article have 
compared the learning curves (LC) of the two approaches. Of interest is that both surgeons had each 
performed almost identical numbers of each procedure. 
 
Assessed parameters and outcomes similar to our study included pre-operative data such as: age at time of 
surgery; PSA level; clinical digital rectal findings; pre-op biopsy Gleason score; and D’amico risk groups. Post-
operative data included: use of nerve sparing surgery; operating time; estimated blood loss; need for 
intraoperative blood transfusion; need for conversion to open surgery; length of post-operative hospital stay; 
pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence status post-
op.  
Assessed parameters and outcomes not included in our study were: prostate weight and complications. This 
study also compared RALP to LRP which was not done in our study.  
 
A total of 1370 patients operated on for their prostate cancer between April 2003-January 2012 at two 
relatively high-volume United Kingdom urological centres were included in the study. Of these surgeon-1 
performed 289 LRPs and 531 RALPs, whereas the surgeon-2 performed 289 LRPs and 550 RALPs. 
 
There were 531 RARP (surgeon-1) patients and 550 LRP (surgeon-2) patients included. Both series were 
divided into consecutive groups of 50 patients and outcomes were then analysed for each group. The number 
of cases to reach a plateau was noted for each outcome per surgeon. Scatterplots were used to assess the 
various outcome measures while locally weighted scatterplot smoothing was used to help determine when 
‘plateau’ of the learning curve was achieved. The authors defined plateau as the point at which increasing 
experience yielded no further improvement in the outcome measured. 
 
Mean overall operating time (OT), excluding robotic setup time, was 124min (range 108–133min) for surgeon-
1’s RALP series, with his plateau for OT being reached at 250 cases. For surgeon-2’ LRP series the mean overall 
OT was reported as 131min (range 127-135min) with his plateau also being reached at 250 cases (p = 0.151).  
 
Mean overall estimated blood loss (EBL) was 272ml (range 207–290ml) for surgeon-1’s RALP series, with his 
plateau for EBL being reached at 250 cases. For surgeon-2’ LRP series the mean overall EBL was reported as 
202ml (range 166-250ml) with his plateau also being reached at 250 cases (p = 0.002). Operative time and 
length of stay were reported as lower in the RARP group, while estimated blood loss was greater. 
 
The median length of hospital stay (LOS) was 1day in surgeon-1 (RALP) series, vs 3days in surgeon-2’s (LRP) 
series.   
   
The overall positive surgical margin (PSM) rate was 14% for surgeon-1’s RALP series, with his plateau for PSM 
rate being reached at 300 cases. Surgeon-1’s PSM rates for pT2 and pT3 were 6% and 31% respectively and it 
was noted that the pT3 PSM learning curve for RARP continues to improve even after 500 cases. For surgeon-
2’ LRP series the mean overall PSM rate was reported as 19% with his plateau also being reached at 200 cases 
(p = 0.001). Surgeon-2’s PSM rates for pT2 and pT3 were 12% and 37% respectively. OT and LOS were reported 
as lower in the RARP group, while EBL was greater. The overall PSM rate and pT2 PSM rate learning curves 
were reported as being longer for RARP 
 
In this study early continence (EC) was assessed in clinic by asking patients how many pads they were using, 
with dry being defined as zero pads in a 24-hour period at 3-month follow-up. Overall EC rates for surgeon-1 
was 77% (plateau at 100 cases), while for surgeon-2 this was reported as 35% (plateau at 350 cases) 
 
Authors concluded that both RALP and LRP had long LC’s. Despite the long LC for RARP, there are benefits to 
patients with RARP over LRP, especially those linked to RALP offering better apical dissection (apical PSM) and 
early return to continence (EC).   
 
This study is applicable to ours in that it includes a series of 531 RALP patients that were analysed in 
consecutive groups of 50 patients, all with similar outcomes to our own study. The use of mean values makes 
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direct comparison difficult. Mention of the number of patients required to reach a plateau in the LC is 
interesting and potentially applicable to our study. The study shows superiority of RALP over LRP once LC 
achieved, which however the LC does not seem to be significantly shorter. 
 
12) Learning Curve Assessment of Robot-Assisted Radical Prostatectomy 
Compared with Open-Surgery Controls from the Premier Perspective 
Database 
Journal of Endourology, Volume 28, Number 5, May 2014 
John W. Davis, Usha S. Kreaden, Jessica Gabbert, and Raju Thomas 
Department of Urology, MD Anderson Cancer Centre, Houston, Texas.  
Department of Clinical Affairs, Intuitive Surgical, Inc., Sunnyvale, California.  
Axistat, Inc., San Francisco, California.  
Department of Urology, Tulane University, New Orleans, Louisiana.  
 
Researchers in the US retrospectively assess the learning curve of robot-assisted laparoscopic radical 
prostatectomy (RALP) by making use of a large administrative database consisting of multiple U.S. hospitals 
and surgeons. The measured outcomes were then used to compare RALP with open radical prostatectomy 
(ORP) from the same settings. 
 
Assessed parameters and outcomes similar to our study included pre-operative data such as: hospitals were 
the surgery was performed; age at time of surgery; and morbid obesity. Post-operative data included: 
operating time; need for intraoperative blood transfusion; need for conversion to open surgery; and length of 
post-operative hospital stay. 
Assessed parameters and outcomes not included in our study was a large focus on complications. This study 
also compared RALP to ORP which was not done in our study. 
 
The patient cohort was taken from the Premier Perspective Database (Premier, Inc., Charlotte, NC) from 2004 
to 2010, and consisted of 71,312 radical prostatectomies (RP) performed at over 300 hospitals in the U.S. by 
up to 3739 surgeons. Final numbers in the RALP and ORP cohorts were 27,348 and 43,964 respectively. The 
key endpoints were surgery time, inpatient length of stay, and overall complications. Also looked at were the 
key endpoints by surgeon case volume.  
 
Within the hospitals with a robot, the mean operating time (OT) for ORP was 204min (standard deviation [SD] 
= 1.5), while for RALP it was 364min (SD = 1.7; p < 0.0001). The mean length of stay (LOS) for ORP was 3.4 days 
while for RALP is was reported as 2.2 days (p < 0.0001). 
 
In terms of looking at the RALP outcomes by case volume, the database for RALP’s was divided into six groups 
of 25 cases, and these were labelled First-25 (n = 5650), Second-25 (n = 4208), Third-25 (n = 2638), Fourth-25 
(n = 1914), Fith-25 (n = 1496), and Sixth-25 (n = 1128). In terms of surgery time the mean OT’s for the six 
groups were: 300min, 270min, 258min; 246min, 240min, and 234min respectively.  
 
For length of hospital stay (LOS) the mean number of days for the six groups were: 2.4days, 2.2days, 2.1days, 
2.0days, 1.9days, and 2.0days sequentially.  
 
The authors of this study concluded that during the initial 7 years of RALP development in the United States of 
America, outcomes showed a trend toward decreased operating time, length of hospital stay, transfusion 
rates, and complications. Learning curve trends for RALP were made evident for these endpoints when 
grouped by surgeon case load.  
 
This study is applicable to ours in that, although it doesn’t look into single surgeon experience and as many 
outcomes as our own study, it does demonstrate that over a very large patient cohort there are improvements 
in the outcomes of OT, LOS, transfusion rate and complications as surgeons gain case volume. 
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13) A comparison of operative and margin outcomes from surgeon learning 
curves in robot assisted radical prostatectomy in a changing referral 
practice 
Ann R Coll Surg Engl 2018; 100: 226–229 
Jaulim, A. Srinivasan, S. Hori, N. Kumar, A.Y. Warren, N.C. Shah, and V.J. Gnanapragasam 
Cambridge University Hospitals NHS Foundation Trust, UK 
 
Researchers at in the UK report the initial experience of three surgeon’s first ever series of robot-assisted 
laparoscopic radical prostatectomies (RALP) between 2005 and 2014 at Addenbrooke’s Hospital. Comparisons 
were made between each of the surgeon’s first and second group of 50 consecutive cases to assess the 
learning curve.  
 
Assessed parameters and outcomes similar to our study included pre-operative data such as: age at time of 
surgery; PSA level; clinical digital rectal findings; and pre-op biopsy Gleason score. Post-operative data 
included: operating time; estimated blood loss; pathological data (i.e. histology and TNM stage); and positive 
surgical margin status.  
Assessed parameters and outcomes not included in our study were: prostate volume and tumour volume  
 
A total of 300 cases, 100 patients for each of the three surgeons, was reviewed. Surgeons were labelled -A, -B 
and -C. The bassline pre-operative outcomes included, for the 300 patients, a median age of 61.5 years (range 
39-74yrs) and a median PSA level of 7.0ng/ml (range 0.5–85ng/ml). For surgeon A to C the median pre-
operative Gleason scores were 6, 6 and 7 respectively.  
 
The operative time (OT) across the three surgeons was 215min. The median OT for surgeons-A, -B and C for 
their first and last 50 patients was: (185 and 180min); (237 and 201min); and (270 and 220min) respectively.  
When looking at each surgeon’s first and last set of 50-patients we can see that surgeon-A’s median OT 
improved by 5min to 180 min, surgeon-B’s improved by 27min to 210min, and surgeon-C’s improved by 50min 
to 220min. The mean estimated blood loss (EBL) across the three surgeons was 252ml The median EBL for 
surgeons-A, -B and C for their first and last set of 50-patients was: (288 and 225ml); (250 and 250ml); and (300 
and 200ml) respectively.  Both OT and EBL were noted to improve progressively as each of the three surgeons 
gained experience, regardless of when their training commenced. 
 
 
The overall to positive surgical margin (PSM) rates for surgeons-A, -B and C were 12%, 20% and 23% for the 
first 50 cases, and 32%, 36% and 21% for the second 50 cases respectively. With regards to positive surgical 
margin rates for pT2 disease for surgeons-A, -B and C for their first and last 50 patients was: (10 and 16%); (13 
and 12%); and (12 and 8%) respectively. For pT3a disease this was: (9 and 53%); (35 and 57%); and (36 and 
30%) respectively, while for pT3b disease this was: (2 and 0%); (4 and 8%); and (6 and 10%) respectively. It was 
commented on by the authors that there was a progressive increase in the proportion of high risk pT3a cases 
for each surgeon series as they took on more changing cases.  
 
The authors of this study concluded that despite an upward trend in high risk referrals for RALP over time, 
there have been no adverse PSM outcomes from surgeons beginning their learning curve at different start 
times. They go on to give the opinion that their study “provides strong reassurance to centres training robotic 
surgeons, as well as evidence to allay patient concerns when their operations are being undertaken by a 
novice robotic surgeon.” 
 
This study is applicable to ours in that it includes a series of 300 RALP patients among three surgeons, each 
with outcomes for their initial 50 cases and then the following 50 cases.  The study is also recent (2018) and 




20   
 
14) Continued improvement of perioperative, pathological and continence 
outcomes during 700 robot-assisted radical prostatectomies 
Canadian Journal of Urology. 2009 Aug; 16(4):4742-9 
Zorn KC, Wille MA, Thong AE, Katz MH, Shikanov SA, Razmaria A, Gofrit ON, Zagaja GP, Shalhav AL. 
Section of Urology, Department of Surgery, University of Chicago Medical Centre, Chicago, Illinois 60637, USA 
 
Researchers in the US retrospectively assess the learning curve and peri-operative outcomes of 700 robot-
assisted laparoscopic radical prostatectomy (RALP) performed by two surgeons in their centre between 2003-
2006. The cases were assessed in groups: Group-1 [cases 1-300], Group-2 [cases 301-500], and Group-3 [cases 
501-700]. 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
positive surgical margin status; and continence and potency status post-op.  
Assessed parameters and outcomes not included in our study were: validated quality-of-life questionnaires 
for continence.  
 
The operating time (OT) was shown to improve with case experience with the mean times for Groups-1, -2, 
and -3 being reported as 286min, 198min and 190min respectively. Estimated blood loss (EBL) and continence 
rates at 1, 3, 6 and 12 months follow up was seen to similarly improve but this did not hold true for potency 
outcomes. pT2 positive surgical margin (PSM) for the consecutive groups were reported as 15%, 10% and 7% 
respectively.  
 
The authors concluded that long learning curves were observed for the parameters of OT, EBL and pT2 PSM 
rates in their study.   
 
This study is applicable to ours in that it provides further proof that although peri-operative parameters are 
shown to improve with surgeon experience, these learning curves are not quick to achieve. 
 
 
15) Robot-Assisted Laparoscopic Radical Prostatectomy: Technique and 
Outcomes of 700 Cases 
International Journal of Biomedical Science. 2009 Sep; 5(3): 201–20 
JR. Carlucci, F. Nabizada-Pace, and DB. Samadi 
Department of Urology, Mount Sinai School of Medicine, New York, USA 
 
Researchers in the US retrospectively assessed the peri-operative outcomes of 700 robot-assisted laparoscopic 
radical prostatectomies (RALP) performed by a single surgeon between May 2007 and October 2008. 
Unfortunately, the patient cohort was not divided into consecutive groups so as to report on the learning 
curve.  
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
need for intraoperative blood transfusion; need for conversion to open surgery; length of post-operative 
hospital stay; pathological data (i.e. histology and TNM stage); positive surgical margin status; and continence 
and potency status post-op.  
Assessed parameters and outcomes not included in our study were: biochemical recurrence rates, quality of 
life date, and complications. 
 
For the entire 700 patient cohort, the overall mean operative time (OT) was defined and skin incision to 
closure and was reported as 124 min. Mean robotic time was defined as time spent by the surgeon at the 
console and was reported as 88min. Mean estimated blood loss (EBL) was 69.3ml and no patients required a 
blood transfusion. 
21   
 
 
Positive surgical margin (PSM) rates were reported as 11.9% overall, and 10%, 40% and 57% for pT2, pT3a and 
pT3b respectively. 
 
The authors conclude that their initial series of 700 cases of RALP show excellent perioperative and 
postoperative outcomes which are congruent with a high-volume surgeon. 
 
This study is applicable to ours in that it provides further reported outcomes of a 700 patient cohort by which 
we can compare our own outcomes. 
 
16) Analysis of the Learning Curve of Surgeons without Previous 
Experience in Laparoscopy to Perform Robot-Assisted Radical 
Prostatectomy. 
Advances in Urology, Volume 2018, Article ID 9073807 
Monnerat Lott F, Siqueira D, Argolo H, Lindberg Nóbrega B, Campos FS, and Favorito LA. 
Brazilian National Cancer Institute, Rio de Janeiro, Brazil. 
Urogenital Research Unit, State University of Rio de Janeiro (UERJ), Rio de Janeiro-RJ, Brazil. 
 
Researchers in Brazil retrospectively assessed the peri-operative outcomes of 119 patients who underwent 
robot-assisted laparoscopic radical prostatectomies (RALP) by two surgeons without previous experience in 
laparoscopic prostatectomy between June 2012 to July 2015. The objective of the study was to assess if the 
learning curve parameters looked at were influenced by the two surgeons lack of previous laparoscopic 
surgical experience. Both surgeons had extensive previous open radical prostatectomy experience. The total 
number of cases were divided into 4 groups based on the year of surgery with Group-1 beings cases operated 
on in 2012, Group-2: 2013, Group-3: 2014, and Group-4: 2015. 
 
Assessed parameters and outcomes similar to our study included retrospectively assessed but prospectively 
collected data including pre-operative data such as: age at time of surgery; PSA level; clinical digital rectal 
findings; pre-op biopsy Gleason score. Post-operative data included: operating time; estimated blood loss; 
length of post-operative hospital stay; pathological data (i.e. histology and TNM stage); positive surgical 
margin status; and continence and potency status post-op.  
Assessed parameters and outcomes not included in our study were: biochemical recurrence rates, prostate 
weight, PSA density; complications and Partin table calculations. 
 
For the entire 119 patient cohort, the overall median operative time (OT) was reported as 180 min. Mean 
estimated blood loss (EBL) was 150ml and no patients required a blood transfusion. Median length of hospital 
stay (LOS) was 2 days. A progressive improvement of continence and sexual potency was reported to be 
observed in their study sample. All parameters assessed showed a trend towards improved outcomes.  
 
The authors concluded that the results of this study, when compared to other reports in the literature, showed 
that a lack of previous laparoscopic surgical did not seem to negatively impact the learning curve outcomes 
they assessed. Although progressive improvements in the outcomes were observed with the passage of time 
and experience the learning curves were not observed to plateau by 119 cases.  
 
This study is applicable to ours in that it provides evidence that previous training in laparoscopic surgery is not 
required in order to show progression in a surgeon’s learning curve during their initial experience in RALP. 
 
17) The surgical learning curve for laparoscopic radical prostatectomy: a 
retrospective cohort study 
Lancet Oncology 2009; 10: 475–80  
Andrew J Vickers, Caroline J Savage, Marcel Hruza, Ingolf Tuerk, Philippe Koenig, Luis Martínez-
Piñeiro, Gunther Janetschek, and Bertrand Guillonneau 
Memorial Sloan Kettering Cancer Centre, New York, USA 
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Researchers in the US retrospectively assess the learning curve of a cohort of 4702 patients with prostate 
cancer (PCa) treated by means if a laparoscopic radical prostatectomy (LRP), by 29 surgeons from seven 
institutions across Europe and the United States, between January 1998 – June 2007. They used multivariable 
models to assess if there was an association between surgeon experience and PCa biochemical recurrence, 
with adjustment for established predictors. 
 
Of note is that this study has very few outcomes and parameters similar to ours and is a large cohort of 
patients who had their prostate cancer managed laparoscopically, not robotically.  
 
1404 of 4702 (30%) of patients (1404 of 4702) were seen by a surgeon who had done less than 100 previous 
procedures, while half (50%, 2349) were seen by a surgeon with experience of more than 250 previous 
procedures. 
 
After adjusting for case mix, greater surgeon experience was associated with a statistically significant lower 
risk of biochemical recurrence at 5-year follow up(p=0·0053). The 5-year risk of biochemical recurrence 
decreased with increasing surgeon experience: 17% (10 cases) to 16% (250 cases) to 9% (750 cases). The risk 
reduction between 10 and 750 cases was reported as 8.0% (95% CI 4.4–12.0). Surgeons with previous 
experience of open radical prostatectomy (ORP) had significantly poorer results than those whose first 
operation was laparoscopic (risk difference 12.3%, 95% CI 8·8–15·7). In summary this study found the learning 
curve to be longer for pure laparoscopic surgery when compared to the open technique, and the results 
improved up to 750 procedures, when they reached a plateau. When the surgeon already had experience in 
open surgery, the results were better. 
 
The authors concluded that the learning curve for LRP was slower than the previously reported learning curve 
for open surgery (p<0·001). Increasing surgical experience is associated with substantial reductions in 
biochemical recurrence after LRP, but improvements in outcome seem to occur at a slower rate than for open 
surgery. Laparoscopic radical prostatectomy seems to involve skills that do not translate well from open radical 
prostatectomy. 
 
This study is applicable to ours in that it demonstrates that different learning curves can be seen within the 
same surgical procedure depending on what outcome you are analysing. In this study the learning curve for 
biochemical recurrence does not appear to plateau even up to 750 cases. 
 
iii) In Summary: 
 
Given the lack of a universally agreed upon definition of a LC nor consistency about which outcomes should be 
measured to track its progress there is a great deal of heterogenicity in the published literature.  Saying that, it 
is clear from above literature that the learning curve (LC) for RALP, indeed any technical procedure, is multi-
faceted in that there is no one universal outcome that can be analysed. Instead there are numerous LC 
outcomes within the overall acquisition of a skill set that ultimately leads to improved functional and 
oncological outcomes.  
These different LC’s include ones for operating times (OT), estimated blood loss (EBL), length of hospital stay 
(LOS), positive surgical margin (PSM) rate, biochemical recurrence (BCR), and complication rate to name a few 
mentioned in our literature review. Each of these tend to show a trend towards overall improvement albeit at 
different trajectories. A common theme among all the articles is that case experience improves outcomes, and 
this can be nurtured within a structured and mentored training program.  
It also becomes clear from our review here that, although there are numerous articles looking at 
predominately American and European LC’s in RALP, there is currently no published data on the South African 
experience. In a country where robotic surgery is in its relative infancy, our study may shed light on what 
outcomes can be expected locally and perhaps encourage patients, surgeons, institutions and funders alike to 
strongly consider RALP as a potential gold standard treatment for localized prostate cancer. 
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b. Abstract  
 
Background and purpose 
Prostate cancer (PCa) is the second most common cancer in men, and the sixth leading cause of cancer death 
among men worldwide (1). Radical Prostatectomy (RP) is widely considered a gold standard treatment for 
clinically significant localized PCa.  Robotic assisted laparoscopic radical prostatectomy (RALP) represents a 
modern minimally invasive technique for performing a RP.  
 
The aim of the study is to demonstrate a progression in the learning curve of two South Africa based 
urologists, as each embarks on their first series of RALP cases between September 2014 to July 2019. An audit 
of peri-operative outcomes for each surgeon’s first uninterrupted series of RALP’s has been undertaken. We 
also compare our results to international series to assess if local South African outcomes are similar to these. 
 
Materials and Methods 
We performed a retrospective audit of all patients who had a RALP with our two urologists between the dates 
of September 2014 to May 2019. Patients were only excluded if critical data could not be collected. For each 
included patient we collected peri-operative data.  
 
Pre-operative data collected was required for risk stratification grouping of patients according the D’Amico 
Risk group classification. Post-operative data included operative details (such as console time and blood loos), 
functional outcomes (such as potency and continence rates), and pathological outcomes (such a T-staging and 
positive surgical margin rates). 
The total number of patients for each of the two surgeons have been divided into a series of consecutive 
groups. The first 100 have been divided into groups of 25, and the subsequent patients into groups of 50. 
 
Results/main findings  
Our two surgeons have been designated Surgeon-X and Surgeon-Y. A total of 700 patients met our inclusion 
criteria, 400 and 300 cases for Surgeons-X and -Y respectively.  Our study demonstrates that in a South Africa 
setting, for the parameters of median console time (CT), estimated blood loss (EBL), length of hospital stay 
(LOS), and positive surgical margins (PSM), there were notable improvements between the first and last 
groups of each surgeon’s series. Although each parameter tends to fluctuate around a median value, there is a 
general trend towards improved outcomes. For the parameters of post-operative continence and potency our 
study failed to show a statistically significant improvement in outcomes between the first and last groups in 
each surgeon’s series. 




This study demonstrates that, similar to internationally published data, notable improvements in peri-
operative outcomes can be observed as each of our two surgeons gain experience in this relatively new 
operative approach to managing men with localized prostate cancer. The overall picture is one of improved 
outcomes with each consecutive group analysed and that when individually assessed, these outcomes display 
differing rates of improvement depending on which is being assessed. When analysing our outcomes of CT, 
EBL, PSM rate and LOS, we see that our results compare favourably to other internationally published data. For 
all intents and purposes our learning curve and peri-operative results are on par with our overseas 








Prostate cancer (PCa) is the second most common cancer in men, and the sixth leading cause of cancer death 
among men worldwide (1). Radical Prostatectomy(RP) is widely considered a gold standard treatment for 
clinically significant localized PCa in men considered eligible for radical treatment.  Radical prostatectomy can 
be offered as open, laparoscopic, or robot-assisted procedure depending on surgeon experience and 
institutional availability of equipment.  
 
Modern urological practice has seen the rise of robotic assisted surgeries, robotic assisted laparoscopic radical 
prostatectomy (RALP) being at the forefront. There has been a rapid increase in the number of American and 
European centers performing RALP over the last decade. The use of robotics in surgery in South Africa is in its 
relative infancy, with only six robot systems operating in the entire country at the time of writing this article.  
 
The benefits of having available to the surgeon a comfortable seated position, magnified binocular 3D 
visualization and number of ergonomic, highly articulated and non-fatigable robotic arms within the tight 
confines of the boney pelvis seem obvious. Although this new approach appears to offer many benefits to 
patients, surgeons and institutions alike, some remain hesitant to adopt it for fear of a difficult learning curve 
that, while undertaken, may compromise functional and oncologic outcomes. As such there has been observed 
a growing interest over recent years in analyzing and understanding the learning process surrounding RALP. 
 
The general definition of a learning curve is the period during which a surgeon finds the procedure more 
technically challenging; takes longer to perform; a higher rate of complications is observed; and there is overall 
lower efficacy because of inexperience. With repetition one typically sees an improvement in these areas with 
obvious benefit to patients, surgeons, institutions and funders alike.  
The aim of the study is to demonstrate a progression in the learning curve of two South Africa based 
urologists, as each embarks on their first ever series of RALP cases between September 2014 to July 2019. 
Given there exists no widely accepted definition nor measure of a learning curve, as a surrogate, we seek to 
assess for improvements in key parameters as each surgeon gains experience with the procedure. An audit of 
these key parameters for each surgeon’s first uninterrupted series of RALP’s has been undertaken. We also 
compare our results to international series with a similar study design, to assess if local South African learning 
curves are similar to these. 
 
The chosen parameters have been selected to be in line with those already defined in already published 
international literature, allowing for better comparisons to be made (2–20). Pre-operative data collected will 
be required for risk stratification grouping of patients according the D’Amico Risk group classification. Post-
operative data included operative details (such as console time and blood loos), functional outcomes (such as 
potency and continence rates), and pathological outcomes (such a TNM staging and positive surgical margin 
rates. 
 
Although available literature reports on similar outcomes in international series, to our knowledge there have 
been no published analysis of South African data. We postulate that in a South African setting we would see 
similar improvements in key parameters and outcomes when compared to international cohorts.  




i) Selection and Description of Participants 
 
We performed a retrospective folder review and included all patients who had a RALP with our two urologists 
at private hospitals. For ethical reasons the two urologist, designated Surgeon-X and Surgeon-Y, as well as their 
identifying patient details have been kept anonymous for the purpose of this study. Surgeon-X recorded his 
very first patient on 29/9/14, while surgeon-Y recorded his on 06/10/15. Patients were only excluded if critical 
data regarding perioperative outcomes could not be collected. A total of two patients were excluded from the 
study for incomplete or missing data. For each included patient we collected peri-operative data. 
Approval for this study was obtained from the University of Cape Town, Department of Surgery Departmental 
Research Committee (Project 2019/023). 
 
Human research ethics committee approval was obtained from the University of Cape Town, Faculty of Health 
Sciences (HREC REF: 218/2019) 
 
ii) Technical Information 
 
We performed a retrospective folder review of all patients with complete records identified during the 
specified time period of September 2014 to July 2019. Surgeon Data was extracted from the clinical folders 
and relevant laboratory records. Pre- and post-operative data was collected.  
Pre-operative data collected will be required for risk stratification grouping of patients according to the 
D’Amico Risk group classification. The pre-operative data collected includes:  
[A] mean age at time of surgery,  
[B] PSA value at diagnosis, 
[C] clinical digital rectal findings (T-Stage), and  
[D] biopsy Gleason score (ISUP grading) 
 
Post-operative data included the following:  
[1] operating/console time, excluding setup/docking time (min), 
[2] estimated blood loss (ml), 
[3] need for intraoperative blood transfusion (yes/no),  
[4] conversion to open surgery (yes/no), 
[5] length of post-operative hospital stay (days),  
[6] number of patients with positive surgical margins (positive/negative),  
[7] percentage of patients in each cohort dry (i.e., not incontinent) at 2/3 and 6 months (%).  
[8] percentage of patients in each cohort potent (i.e., not suffering from erectile dysfunction) at 2/3 
and 6 months (%).  
[9] histological (i.e., Gleason scope or ISUP grading), and  
[10] pathological (i.e. T-staging, not N or M staging) data.  
 
Information regarding post-operative incontinence was assessed by asking the patients if they were wet or dry 
post op. Although Surgeon-Y made efforts to quantify the number of pads wet for each patient, this was not 
done by Surgeon-X and was therefore not included for assessment. The completely continent rate was 
calculated by dividing the number of patients in each group who reported being completely dry (i.e. no leak or 
pads), by the total number of patients in each group for who such data was recorded.  Information regarding 
potency was more formally assessed by each of the surgeons using the validated International Index 
of Erectile Function (IIEF-5) score. Both surgeons collected data regarding incontinence and potency, surgeon X 
at 2- and 6-months post op, while surgeon Y at 3- and 6-months post op. 
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The total number of patients for each of the two surgeons have been divided into a series of consecutive 
groups. The first 100 have been divided into groups of 25, and the subsequent patients into groups of 50. 
These groups for each surgeon have been designated as Group-A [1-25]; Group-B [26-50], Group-C [51-75], 
Group-D [76-100], Group-E [100-150], Group-F [151-200], Group-G [201-250], Group-H [251-300], Group-I 
[301-350], and Group-J [351-400].  
 
iii) Statistics  
 
Continuous and interval data were described in terms of mean (standard deviation) or median (interquartile 
range) as appropriate for the data distribution. Categorical data were described as counts and proportions.  A 
series of Mann-Whitney U tests compared (a) median console time, and (b) IIEF at 6/8 weeks, 6 months and 12 
months between surgeons for each of Groups A-H (a series of independent sample t-tests did the same 
analyses for mean length of hospital stay). Kruskal-Wallis tests compared median console time and EBL across 
groups A-H for each surgeon (a one-way ANOVA did the same analysis for mean length of hospital stay). Chi-
square tests were used to determine the association between surgeon and (a) D’amico classification, (b) 
proportion of patients discharged within one day, (c) PSM rate, and (d) pathological stage for all their patients 
and then within each group (A-H). Where sample sizes were too small, Fisher’s Exact test were performed and 
described in the results section below. Chi-square tests were also used to determine the association between 
surgeon and patient incontinence at 6/8 weeks, 6 months and 12 months, for all patients and within each 
group of patients (A-H).   
 
The a priori level of significance was either set at 0.05, or Bonferroni corrected (noted in the results section 
when corrections were made). All statistical analyses were performed using Sstatistical Package for Social 




Our two surgeons have been designated Surgeon-X and Surgeon-Y. A total of 700 patients met our inclusion 
criteria, 400 patients in Surgeon-X’s cohort, and 300 patients in Surgeon-Y’s cohort. All patients had biopsy-
confirmed adenocarcinoma of the prostate. The pre-operative clinical characteristics of the patients for both 
surgeons are summarized in table-1. Of importance to note is that although baseline age and pre-operative 
PSA levels were similar between the cohorts, there were significant differences in the biopsy ISUP grading and 
D’amico risk groupings (see figure 1).  
 
There was a significant association between pre-operative D’amico classification and Surgeon (χ2 = 52.37, p < 
.001, V = 0.27). A significantly higher proportion on Surgeon-Y’s patients were classified as Low Risk, whereas a 
significantly higher proportion of Surgeon-X’s patients were High Risk. When analysing the sub-groups of 
patients, the association between D’amico classification and Surgeon was only significant in Groups-E (p = 
.001) and -F (p < .001).  
 
A breakdown of each surgeon’s pathological (pT) staging per group can be found in figure-1 
 
Analysis of Console Times and Conversion to Open Surgery: 
Neither of our two surgeons reported any of their patients requiring conversion to open surgery. Median 
console times (CT) in minutes was calculated for both surgeons (see figure-2). The CT refers to the length of 
time that the surgeon was operating the robot from the console and did not include anaesthetic nor robot 
setup/docking times.  For Surgeon-X the respective CT’s for Groups A to H were: 230min; 177min; 145min; 
142min; 130min; 106min; 108min; 115min; 107min, and 113min. For surgeon-Y the respective CT’s for Group 
A to H were: 196min; 150min; 134min; 142min; 133min; 120min; 113min; and 120min.  
The overall median CT for Surgeon-X (n=400) was 123min [range 68-296 min]. For Surgeon-X there were 193 
patients (48%) that had console times less than or equal to 120min, with only 9 (<5%) of these coming from 
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groups-C and -D combined, while the remainder came from Group-E onwards (i.e. >100 patients). For Surgeon-
X there were 42 patients (10.5%) that had console times of less than or equal to 90min, these occurred 
exclusively from Group-F onwards (i.e. > 150 patients).  
The overall median CT for Surgeon-Y (n=300) was 129min [range 63-263 min]. For Surgeon-Y there were 125 
patients (41.6%) that had console times less than or equal to 120min with 6 (<5%) of these coming from 
groups-C and -D combined, while the remainder came from group-E onwards (i.e. >100 patients). There were 
21 patients (7%) that had console times of less than or equal to 90min, these occurred exclusively from Group-
E onwards (i.e. >100 patients).  
The Kruskal-Wallis test showed that for both Surgeons, median CT differed significantly between sub-groups of 
patients (Surgeon-X: H = 141.9, p < .001; Surgeon Y: H = 100.3, p < .001). For Surgeon-X, median CT was 
significantly faster in Group-F compared to Groups A-D; Group-G compared to Groups A-D; Group-H compared 
to Groups -A, -B and -D; Group-J compared to -A, -B and -D; Group-D compared to Groups-A and -B; and 
Group-C compared to Group-A (see table-3). For Surgeon-Y, median CT was significantly faster in Group-G 
compared to Groups A-E; Group-F compared to Groups-A and-B; Group-H compared to Groups-A and -B, and 
Groups -C, -D and -E compared to Group -A (see table-3).  
 
Analysis of Estimated Blood Loss: 
Median estimated blood loss (EBL) in ml was calculated for both surgeons (see figure-3). The overall median 
EBL for Surgeon-X was 75ml [range 0-700 ml], while for Surgeon-Y it was 200ml [range 20-1200ml]. For 
Surgeon-X the EBL for Groups A to J was: 200ml; 100ml; 100ml; 50ml; 60ml; 50ml; 50ml; 55ml; 78ml; and 50ml 
respectively. For Surgeon-Y the EBL for Groups A to H was: 200ml; 150ml; 100ml; 200ml; 200ml; 188ml; 178ml; 
and 200ml respectively. Surgeon-X did not report a requirement for intra-operative blood transfusion, while 
Surgeon-Y reported only 2 cases in his entire series. 
 
Analysis of Length of Post-Operative Hospital stay: 
Mean length of hospital stay (LOS) was for both surgeons was calculated. The overall mean LOS for Surgeon-X 
was 1.7days [range 1-9 days], while for Surgeon-Y it was 1.5days [range 1-10 days]. For Surgeon-X the mean 
LOS for groups A to J was: 2.2; 1.7; 1.3; 1.7; 2.0; 1.2; 1.0; 2.0; and 2.0 days respectively. For Surgeon-Y the 
mean LOS for groups A to H was: 1.7; 1.9; 1.7; 2.0; 1.0; 1.4; 1.0 and 1.0 days respectively.  
Significant between-surgeon differences were found in Group-C, with Surgeon-Y’s patients having a 
significantly longer hospital stay (see table-5). A one-way ANOVA showed that there was a statistically 
significant difference between LOS and Group for Surgeons-X and Surgeon-Y [Surgeon X: F(9,390) = 3.97, p < 
.001; Surgeon-Y: F(7,290) = 2.36, p = .023]. For Surgeon-X, pairwise post-hoc comparisons showed that the 
differences lay between Group-A and -F (p = .004), Group-A and-G (p = .010), Group-F and -I (p = .029), Group-F 
and -J (p = .009), and Group-G and -J (p = .029). For Surgeon-Y, at the Bonferroni corrected p-value, there were 
no significant between-group differences. 
 
We also calculated the percentage of patients discharged on day one after surgery for both surgeons (see 
figure-4). For Surgeon-X the percentage of patients discharged on day one for groups A to J was: 20%; 52%; 
72%; 52%; 54%; 78%; 74%; 60%; 44%; and 58% respectively. For Surgeon-Y for groups A to H this percentage 
was: 40%; 24%; 40%; 40%; 66%; 64%; 68%; and 80% respectively. 
A significantly higher proportion of patients were discharged after one day for Surgeon-X in Groups-B (p = 
.041) and C (p = .023), and a higher proportion were discharged for Surgeon-Y in Group-H (p = .029). 
Irrespective of Group, 58% of patients for both Surgeons were discharged after one day (see table-6) 
 
Analysis of Positive Surgical Margins: 
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Oncologic outcome is the most significant endpoint for patients with prostate cancer receiving radical 
prostatectomy. The percentage of patients in each group with pathological positive surgical margins (PSM) was 
calculated for both surgeons (see figure-5). A PSM was defined as the presence of cancer cells at the inked 
margin. For Surgeon-X the PSM rate for Groups A to J was: 24%; 32%; 16%; 44%; 18%; 22%; 20%; 22%; 26%; 
and 22% respectively. For Surgeon-Y the PSM rate for Groups A to H was: 16%; 8%; 8%; 4%; 8%; 8%; 2% and 
4% respectively.  
Whenever discussing PSM with regard to prostate cancer we already know that there is an association 
between the pathological stage of the tumour (pT) and the risk of obtaining a PSM. It thus becomes important 
to assess the pathological staging of each surgeons’ sub-groups (see figure-6). Pathological Stage (pT) for 
Surgeon-X was significantly different compared to Surgeon-Y (p <.001). A significantly higher proportion of 
patients for Surgeon-X were stage pT2. When comparing sub-groups of patients between surgeons, a 
significantly higher proportion of patients for Surgeon-X were stage pT2 across all groups, and a significantly 
higher proportion of patients for Surgeon-Y were stage pT1 for Groups A and B and Stage pT3 for Groups B – E. 
The PSM rate for Surgeon-X for his entire series of 400 patients is 23.5%(n=94), with 34% of PSM’s (32/94) 
being pT2 disease while 66% (62/94) were pT3 disease on final histology. For Surgeon-X the PSM rate was 
11.7% (32/274) and 50.4% (62/123) for pT2 and pT3 disease respectively. The PSM rate for pT3 disease for 
Surgeon-X from Groups A to J was: 60%; 100%; 66.7%; 80%; 58.3%; 50%; 44.4%; 36.4%; 58.8%; and 43.5% 
respectively (see figure-7). 
The PSM rate for Surgeon-Y for his entire series of 300 patients is 6.7% (n=20), with none of the PSM’s being 
pT2 disease, while 95% (19/20) were pT3 disease and 5% (1/20) were pT4 disease on final histology. For 
Surgeon-Y the PSM for pT3 disease was 12.2%(19/156) and for pT4 disease was 10% (1/10). The PSM rate for 
pT3 disease for Surgeon-Y from Groups A to H was: 80%; 14.3%; 16.7%; 5%; 11.1%; 10%; 6.3%; and 8.7% 
respectively (see figure-7). 
For Surgeon-X (χ2 = 70.4, p < .001, V = 0.42) and Surgeon-Y (χ2 = 16.05, p < .001, V = 0.24), the PSM rate was 
significantly higher among pT3 disease (see table-7). When comparing sub-groups of patients, the PSM rate 
was significantly higher among pT3 disease in Groups E to J for Surgeon-X, and only in Group-A for Surgeon-Y 
(see table-8). 
 
Analysis of Post-Operative Continence: 
The completely continent rate, defined in methods, was calculated for each surgeon.  
For Surgeon-X the completely continent rate at 8 weeks and 6 months post RALP for Groups A to H was: 
(54.2% and 97%); (41.7% and 94%); (52% and 98%); (44.2% and 98%); (52% and 93%); (63.3% and 96%); (72.7% 
and 97%); (64.3% and -%) respectively. In Groups-I and -J there was insufficient data at 6 weeks and 6 months 
follow-up, as well at 6 weeks follow up in group-H, to make any definitive conclusions and so these results 
have been omitted.    
For Surgeon-Y the completely continent rate at 6 weeks and 6 months post RALP for Groups A to G was: (80% 
and 96%); (68% and 0%); (80% and 0%); (65% and 95.7%); (52% and 98%); (61% and -%); and (39% and -%) 
respectively. In Groups-G and -H there was insufficient data at 6 months follow-up to make any definitive 
conclusions and so these results have been omitted.    
 
Analysis of Post-Operative Potency: 
Median International Index of Erectile Function (IIEF-5) scores were calculated for both surgeons. 
Unfortunately, pre-operative potency scores were only assessed in Surgeon-Y’s cohort, not Surgeon-X’s, with a 
median score of 20. For both surgeons the majority of patients were performed as either a unilateral or 
bilateral nerve sparing procedure where it was considered oncologically sound to do so.  
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For Surgeon-X the percentage of men considered potent, defined as an IIEF-% score ≥16, at 8 weeks and 6 
months post RALP for groups A to I was: (15% and 20%); (9.5% and 11%); (8.7% and 13%); (4.3% and 17%); 
(2.1% and 7%); (6.4% and 7%); (2.1% and 7%); (2.1% and -%); and (9.5% and -%) respectively. In Groups-H and I 
there was insufficient data at 6 months follow up, as well as Group-J at both 6-week and 6-month follow-up, to 
make any definitive conclusions and so these results have been omitted. 
For Surgeon-Y the percentage of men considered potent, defined as an IIEF-% score ≥16, at 6-weeks and 6-
months post RALP for Groups A to H was: (28% and 41.7%); (28% and 37.5%); (30.4% and 39.1%); (35.3% and 
47.1%); (32.6% and 42.2%); (24.5% and -%); (38.6% and -%); and (35% and -%) respectively. In Groups-F to -H 
there was insufficient data at 6-months follow-up to make any definitive conclusions and so these results have 
been omitted 
 
Analysis of Results in Consecutive Groups of 100 cases: 
We then divided each surgeon’s series into groups of 100 cases.  For Surgeon-X there was significant increase 
in the mean LOS between both the second (p = 0.001) and third (p = 0.001) 100 patients and the last 100 
patients. There was a significant decrease in median CT between the first 100 patients and all subsequent 
groups. EBL only significantly decreased between the first 100 patients and the second (p = 0.006) and third (p 
= 0.010) 100 patients.  
 
For Surgeon-Y there was a difference in mean LOS between the groups, the first 100 patients had a median of 
2 days, all subsequent groups were 1 day. There was a significant decrease in median console time between 
the first 100 patients and all subsequent groups (all ps < .007). Estimated blood loss did not differ between 
groups (p = 0.257). 
 
There was no significant change in PSM rates between the groups for either surgeon ’s series (X: p = 0.436; Y: p 
= 0.190). However, for Surgeon-X, the PSM rate was significantly higher in pT2 disease for the first 100 patients 
(p = 0.009) compared to subsequent groups of patients. No other significant differences were found.  
 
 
f.    Discussion 
 
Summary of Findings 
 
To our knowledge there are currently no large-scale studies of RALP outcomes that have been reported in 
South Africa. Our study of 700 patients who underwent RALP demonstrates that in a South Africa setting, for 
the parameters of median console time (CT), estimated blood loss (EBL), length of hospital stay (LOS), and 
positive surgical margins (PSM), there were notable improvements between the first and last groups of each 
surgeon’s series. Although each parameter tends to fluctuate around a median value, there is a general trend 
towards improved outcomes. These can be seen depicted in the slope of each parameters trendline (see 
figures 2-5 and 7), except for Surgeon-Y’s EBL trendline (see figure-3).  
 
There was a significant reduction in the median CT (p < 0.001), EBL (p < 0.001), mean LOS (p = 0.002) between 
the first and last groups of Surgeon-X’s series. Surgeon-X did not have a further statistically significant 
improvement in any outcome variables in his following two groups (I-J). While there was a significant reduction 
in the median CT (p < 0.001) between the first and last groups of surgeon-Y’s series, there was no significant 
change in median EBL (p = 0.861) or mean LOS (p = 0.306). There was also no significant change in positive 
surgical margins between the first and last groups of each surgeon’s series (X: p = 0.845; Y: p = 0.091). 
Furthermore, PSM rate among pT2 (p = 0.492) and pT3 (p = 0.316) disease did not differ between the first and 
last groups for Surgeon-X’s series. For Surgeon-Y, no patients with pT2 disease had a PSM in either the first or 
last groups. However, a higher proportion of patients with pT3 disease had a PSM in the first compared to the 
last group (p = 0.013). 
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Several initial reports on RALP having a favourable learning curve exist (2,5,7), with the eminent robotic 
surgeon Dr VP. Patel reporting that as little as 20-25 cases are required in order to complete the learning curve 
of RALP. These reports make the use of RALP rather appealing considering other studies that report a learning 
curve for laparoscopic radical prostatectomy (LRP) being approximately 250 cases (6,18,21), with some 
learning curve parameters not reaching a plateau even after 750 cases (22).  
 
These early series however, were unlikely to have sufficient numbers to identify the plateau of the learning 
curve, that is a number of cases required to no longer demonstrate notable improvements in outcomes. In 
fact, every procedure and surgeon is likely to have their own distinct learning curve with the number of cases 
required to become adept varying widely. Add to this that in our study, as in most studies examining a learning 
curve for a surgical procedure, there are differing numbers of cases required to become proficient depending 
on which parameter is being assessed. In other words, there are different learning curves within the overall 
learning curve for RALP.  
 
This can be demonstrated in a study by Eden et al (18) reported that the learning curve for both OT and EBL 
plateaued within the first 100-150 cases, while that for both complication and continence rates took longer at 
150-200 cases to reach a plateau. The parameter that took the longest to plateau was potency at 700 cases. 
Thompson et al (4) reported that odds of a pT2 PSM in their series of RALP’s only started to become lower 
after 108 cases and reduced by 55% (OR: 0.45; 95% CI, 0.22–0.92) by the 866th RALP. In the same study the 
odds of a pT3/4 PSM started to plateau only around 200–300 RARPs with an OR of 1.15 (0.68–1.95) at the 
866th RALP. This study also reported potency only reaching a plateau in learning curve around 600-700 cases. 
A multi-institutional review of 3794 patients showed a learning curve of >1000 cases before the pT3 PSM rate 
plateaued. The results of a study by Sooriakumaran et al (3) involving 3974 patients undergoing RALP suggest 
that proficiency in RALP involves a much longer learning curve than previously recognized. Mean operating 
time plateaued only after 750 cases, while 1600 cases would be required to get an overall PSM rate of <10%. 
All these studies seem to support the notion of RALP being centralized in a small number of high-volume 
centres where the relevant surgeons may attain the case experience required to offer their patients outcomes 
of the highest calibre.  
 
In our series we saw that when assessing CT for Surgeon-X, at Group-C it is faster than Groups -A and -B but 
only seems to plateau by Group-F. For Surgeon-Y, CT at Group-C it is faster than Groups -A and -B and then 
plateaus.  When assessing EBL for Surgeon-X, we saw that at group-F it seems to be lower to other subsequent 
groups. However, this isn’t the plateau because for groups H-J it increases again. Surgeon-Y was not 
demonstrated to reach a plateau for EBL. No plateaus for the variables of LOS nor PSM could be conclusively 
demonstrated in either surgeon’s series.  For the parameters of post-operative continence and potency our 
study failed to show a statistically significant improvement in outcomes between the first and last groups in 
each surgeon’s series. This is consistent with other internationally published data that reports a high case load 
(>700) in order to demonstrate a plateau in the learning curve for these parameters.  
Although this study was not intended as a comparison between our two surgeons, of interest is the 
discrepancy in PSM rates between Surgeon-X and -Y (see table-2 and figures 5 and 7). Although Surgeon-Y 
appears to have a significant lower overall PSM rate (23.5% vs 6.7%) and pT3 PSM rate (50.4% vs 12.2%) it 
should be noted that significantly higher proportion of Surgeon-X’s patients were assessed as D’amico High 
Risk (see figure-1) and he had higher percentages of pT3 disease in his later series (see figure-6) when 
compared to Surgeon-Y. Other suggested potential confounder here are the fact that for Surgeon-Y, 273/300 
(91%) of the patients in his cohort had a pre-operative multiparametric MRI, while for Surgeon-X this number 
was substantially lower. This may highlight a potential selection bias for Surgeon-Y’s series of cases. 
Additionally, Surgeon-Y is noted to have been exposed to considerably more laparoscopic surgery prior to the 
initiation of his RALP series than was Surgeon-X. A study by Tobias-Machado et al (13) showed that 
experienced laparoscopic surgeons were able to attain peri-operative and functional outcomes similar to 
surgeons who have high levels of experience in RALP, and so this may have an impact in the differences in 
outcomes. 
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When comparing our series of 700 patients to that of other contemporary international series (see table-9) we 
can see that the parameters of operating time (OT), EBL, LOS and PSM rate appear to be as favourable in our 
setting as in those reported overseas. If we use Coelho et al’s “critical review of pentafecta outcomes” (26) as a 
direct comparison, we can see that our CT is better (125min vs 174min); our EBL is better (100ml vs 185.8ml); 
and our LOS is the same (1.6days vs 1.58days). This comparison is especially true for the important parameters 
of PSM rates were we see that our overall PSM rate is similar (16.2% vs 14.8%); our pT2 PSM rate is slightly 
better (7.7% vs 8.92); and our pT3 PSM rate is also slightly better (29% vs 33%). As this study depicts the 
weighted mean values of 17-19 different international studies, with a total patient cohort of more than 11,500 
cases, we feel this is probably the one study that likely represents a fair overall impression of how our results 
compare to international series.  
Of particular interest is the progression in parameters in the four consecutive 200, 500, 1500, 2500 and 4000 
patient series of Patel et al (2,12,14, 23, 26) that fail to show dramatic improvements in most of the recorded 
parameters, excepting console time, at even very high single surgeon case experience.  
 
Limitations of our study 
 
We recognise the limitations in our study being of a retrospective nature. We also acknowledge that the 
number of cases performed by each of our surgeons may be insufficient to adequately demonstrate a plateau 
in all of the learning curve parameters assessed. If the above-mentioned studies are a true reflection of the 
numbers needed to demonstrate a plateau, each surgeon would need to perform an excess of 1000-1500 
cases for all the learning curves to revel themselves.  
 
Furthermore, there are potential confounders that would very likely affect difficulty of a RALP that were not 
fully assessed in our study. These include: ASA-score, body mass index (BMI), use of pre-operative 
multiparametric MRI, previous abdominal surgery, and previous treatments for prostate cancer (i.e. a salvage 
prostatectomy being performed).  
 
We also recognise that some the parameters assessed, such as CT and LOS, may be a factor of the strengths 
and weaknesses of factors outside of the surgeon’s control. For instance, the number of days a patient remains 
in hospital post-surgery may be a reflection of inadequate pain control or lack of skilled nursing care. 
 
Additionally, the fact that each surgeon made use of different pathology labs to assess their radical 





This study demonstrates that, similar to internationally published data, notable improvements in peri-
operative outcomes can be observed as each of our two surgeons gain experience in this relatively new 
operative approach to managing men with localized prostate cancer. The overall picture is one of improved 
outcomes with each consecutive group analysed and that when individually assessed these outcomes display 
differing rates of improvement depending on which is being assessed. When analysing our outcomes of CT, 
EBL, PSM rate and LOS, we see that our results compare favourably to other internationally published data. For 
all intents and purposes our learning curve and peri-operative results are on par with our overseas 
counterparts and in some cases better.    
 
Our study also confirms that RALP can feasibly, safely and effectively be introduced in a South Africa setting 
without functional and oncological outcomes being compromised. Within a structured training and mentorship 
program it is our feeling that satisfactory outcomes can be achieved along the demonstrated learning curves 
for those novice surgeons willing to dedicate themselves to this surgical approach. We would agree with the 
concept of RALP being taught to surgeons and offered to patients in a smaller number of high-volume centres 
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that will more likely attain the high case experience required to reach their optimal learning curve and thus 
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Table 2: Patient Post-Operative Characteristics for Surgeon-X and Surgeon-Y 
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Table 3. Console time (CT) for both surgeons by sub-groups 
  Surgeon-X Surgeon-Y    
Group n Median IQR Median IQR U p r 
A 25 230 186.5 - 254.5 196 178.5 – 230 214.5 .057 0.38 
B 25 177 177 – 198.5 150 132.5 - 180 207.5 .042* 0.41 
C 25 145 122.5 – 150.5 134 120 – 158 284.5 .587 0.11 
D 25 142 125.5 - 175 142 122 – 150 265 .356 0.18 
E 50 129.5 110 – 145.5 132.5 119.5 - 160 1099.5 .299 0.15 
F 50 106 96.8 – 129 120 103.8 – 140 904 .017* 0.34 
G 50 107.5 95.5 - 134 112.5 100 – 125.8 1173.5 .598 0.07 
H 50 114.5 93.8 – 136.3 120 105 - 130 1102.5 .309 0.14 
I 50 106.5 93 – 131      
J 50 113 95.5 – 129.3      
Note. *p < .05. **p <.006 (at the Bonferroni corrected level). 
 
 
Table 4. Estimated Blood Loss (EBL) for both surgeons by sub-groups 
  Surgeon X Surgeon Y    
Group n Median IQR Median IQR U p r 
A 25 200 150 - 400 200 100 - 350 290.5 .667 0.09 
B 25 100 75 - 100 150 100 - 225 193.5 .014* 0.49 
C 25 100 50 - 120 100 50 – 300 241.5 .157 0.28 
D 25 50 50 - 80 200 150 - 275 76.5 <.001** 0.94 
E 50 60 50 - 100 200 100 - 300 504.5 <.001** 0.73 
F 50 50 50 - 100 187.5 100 – 357.5 451 <.001** 0.79 
G 50 50 50 - 100 177.5 100 – 300 419 <.001** 0.82 
H 50 55 50 - 100 200 150 - 350 407 <.001** 0.84 
I 50 77.5 50 - 100      
J 50 50 50 - 100      
Note. *p < .05. **p <.006 (at the Bonferroni corrected level). 
 
 
Table 5. Length of hospital stay (LOS) for both surgeons by sub-groups 
  Surgeon-X Surgeon-Y    
Group n Mean SD Mean SD t p d 
A 25 2.2 1.0 1.7 0.7 1.99 .053 0.58 
B 25 1.7 0.9 1.9 0.6 -0.72 .475 0.26 
C 25 1.3 0.6 1.7 0.6 -2.15 .037* 0.67 
D 25 1.7 1.0 2.0 1.7 -0.92 .364 0.22 
E 50 1.6 0.7 1.4 0.6 1.34 .183 0.31 
F 50 1.2 0.5 1.448 0.7 -1.09 .280 0.33 
G 50 1.3 0.5 1.3 0.9 -0.28 .784 >0.01 
H 50 1.5 0.8 1.4 1.4 0.45 .656 0.09 
I 50 1.9 1.2      
J 50 2.0 1.8      
Note. *p < .05. **p <.006 (at the Bonferroni corrected level). 
41   
 
 
Table 6. Proportion of patients discharged after one day for both surgeons by sub-groups  
 
  Surgeon-X Surgeon-Y    
Group n % % χ2 p V 
A 25 20 40 2.38 .123 0.22 
B 25 52 24 4.16 .041* 0.29 
C 25 72 40 5.19 .023* 0.32 
D 25 52 40 0.73 .395 0.12 
E 50 54 6549 1.31 .252 0.12 
F 50 78 6948 1.08 .300 0.11 
G 50 74 68 0.44 .509 0.07 
H 50 60 80 4.76 .029* 0.22 
I 50 44     
J 50 58     




Table 7. Positive Surgical Margin (PSM) rate for both Surgeons by Pathological Staging (pT) 
 
Path Stage Surgeon-X  Surgeon-Y 
PSM pT2  32/274 (11.7%) 0/125 (0%) 
PSM pT3 62/123 (50.45%) 19/156 (12.2%) 
  
 
Table 8. Positive Surgical Margin (PSM) rate for both Surgeons by Pathological Staging (pT) 
 
 Surgeon X Surgeon Y 
 PSM pT2 PSM pT3 p V PSM pT2 PSM pT3 p V 
A 3/20 3/5 .070 0.42 0/11 3/4 .009* 0.83 
B 6/22 2/2 .101 0.43 0/5 2/11 .458 0.26 
C 2/21 2/3 .061 0.51 0/13 2/12 .220 0.31 
D 7/20 4/5 .096 0.36 0/5 1/20 .800 0.10 
E 2/37 7/12 <.001** 0.59 0/13 4/35 .269 0.18 
F 3/34 8/16 .002* 0.46 0/18 3/30 .235 0.20 
G 2/34 8/18 .002* 0.46 0/33 1/15 .313 0.22 
H 3/28 8/22 .034* .307 0/27 2/23 .207 0.22 
I 3/33 10/17 <.001** 0.54     
J 1/27 10/23 .001** 0.48     
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Table 9. Comparison of reported outcomes in published contemporary series 
 
 
Year = year of publication; OT = Operating Time; EBL = estimated blood loss; LOS = length of hospital stay; D/C day 1 = rate of 
discharge day one after surgery 
The first five studies (darkened) represent successive publications of a single surgeon’s (Dr VP. Patel) experience in RALP 





i. Illustrations (Figures) 
 
Figure 1. Surgeon-X and -Y D’amico risk Assessment percentage for both surgeons by sub-groups 
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Figure 2. Median Console Times (CT) for both surgeons by sub-groups 
 
 






























































Median Estimated Blood Loss
Surgeon-X Surgeon-Y
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Figure 4. Percentage of Patients Discharged Day One Post Surgery for both surgeons by sub-groups 
 
 


















































































Positive Surgical Margin Rate
Surgeon-X Surgeon-Y
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Positive Surgical Margin Rate for Pathological T3 disease
Surgeon-X Surgeon-Y
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 j.   Units of Measurement 
 
 
operating/console time, excluding setup/docking time (min)  
estimated blood loss (ml) 
length of post-operative hospital stay (days) 
histological outcomes (i.e., Gleason scope or ISUP grading);  
pathological data (i.e. TNM staging).  
 
 
k.   Abbreviations and Symbols 
 
PCa: Prostate Cancer 
PSA: Prostate-Specific Antigen 
 
LRP: Laparoscopic Radical Prostatectomy 
 
ORP: Open Radical Prostatectomy 
RALP: Robotic Assisted Laparoscopic Radical Prostatectomy 
CT: Console Time  
OT: Operating Time 
EBL: Estimated Blood Loss 
LOS: Length Of post-operative hospital Stay 
PSM: Positive Surgical Margin 
ASA: American Society of Anesthesiologists  
ISUP: International Society of Urological Pathology 
BMI: Body Mass Index 
IIEF-5: International Index of Erectile Function score. 
 
l. Appendices  
 
i) Department of Surgery departmental research committee approval letter 
 
ii) UCT HREC approval letter 
 





i) Department of Surgery departmental research committee approval letter
Signature Removed
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ii) UCT HREC approval letter
Signature Removed
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iii) CMJE recommendations for conduct and reporting of research published in medical journal 
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